Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28249141

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Mar 2
First author
Kantarjian H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2017 May;14(5):264. doi: 10.1038/nrclinonc.2017.42.
    note
    Source null
    related pmid
    28322244
    relationship
    Comment in
  2. citation
    N Engl J Med. ;376(23):e49. doi: 10.1056/NEJMc1704012.
    note
    Source null
    related pmid
    28594155
    relationship
    Comment in

Authors and identifiers

  1. name
    Kantarjian H
    type
    Author
  2. name
    Stein A
    type
    Author
  3. name
    Gökbuget N
    type
    Author
  4. name
    Fielding AK
    type
    Author
  5. name
    Schuh AC
    type
    Author
  6. name
    Ribera JM
    type
    Author
  7. name
    Wei A
    type
    Author
  8. name
    Dombret H
    type
    Author
  9. name
    Foà R
    type
    Author
  10. name
    Bassan R
    type
    Author
  11. name
    Arslan Ö
    type
    Author
  12. name
    Sanz MA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kantarjian H
    type
    Author
  2. name
    Stein A
    type
    Author
  3. name
    Gökbuget N
    type
    Author
  4. name
    Fielding AK
    type
    Author
  5. name
    Schuh AC
    type
    Author
  6. name
    Ribera JM
    type
    Author
  7. name
    Wei A
    type
    Author
  8. name
    Dombret H
    type
    Author
  9. name
    Foà R
    type
    Author
  10. name
    Bassan R
    type
    Author
  11. name
    Arslan Ö
    type
    Author
  12. name
    Sanz MA
    type
    Author
bibliography ids
  1. nci-bib-02f21440fcd41c987c49bf3d
book metadata
content sha256
e758b7ad6c7d9f96b7b91ba85c1ca8d0b319a9d1ef19469750554b9511a03423
document type
citation
dois
  1. 10.1056/NEJMoa1609783
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:28249141
immutable id
pubmed:28249141@e758b7ad6c7d9f96b7b91ba85c1ca8d0b319a9d1ef19469750554b9511a03423
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
9
name
The New England journal of medicine
nlm unique id
0255562
pages
836-847
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2017 May;14(5):264. doi: 10.1038/nrclinonc.2017.42.
    note
    Source null
    related pmid
    28322244
    relationship
    Comment in
  2. citation
    N Engl J Med. ;376(23):e49. doi: 10.1056/NEJMc1704012.
    note
    Source null
    related pmid
    28594155
    relationship
    Comment in
outcomes validated
false
pmid
28249141
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
f8888b4cba7e48a980bd8ca9b1e9ba30dbe6a391a9243038ba4f455a9be755ee
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Mar 2
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28249141/
title
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Preserved source evidence · Not medical advice